Clinicopathologic Analysis of 187 High-grade Endometrial Carcinomas of Different Histologic Subtypes: Similar Outcomes Belie Distinctive Biologic Differences

No abstract is available for this paper.

• Publication year

  2007

• Venue

  American Journal of Surgical Pathology

• Publication date

  2007-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/PAS.0b013e31802ee494PMID 17592263
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Minimal uterine serous carcinoma: a clinicopathological study of 40 cases

  2005influential reference
• Description of a Novel System for Grading of Endometrial Carcinoma and Comparison With Existing Grading Systems

  2005cited by this paper
• Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome): Criteria for Identification and Management

  2005cited by this paper
• Uterine serous and grade 3 endometrioid carcinomas

  2004cited by this paper
• Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium.

  2004cited by this paper
• Prognostic parameters of endometrial carcinoma.

  2004cited by this paper
• Wilms Tumor Gene (WT1) and p53 expression in endometrial carcinomas: a study of 130 cases using a tissue microarray.

  2004cited by this paper
• Serous Endometrial Cancers That Mimic Endometrioid Adenocarcinomas: A Clinicopathologic and Immunohistochemical Study of a Group of Problematic Cases

  2004cited by this paper
• Outcome and patterns of failure in pathologic stages I-IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy.

  2003cited by this paper
• Pathological findings in early-stage endometrial cancer.

  2003cited by this paper
• Significance of comprehensive surgical staging in noninvasive papillary serous carcinoma of the endometrium.

  2003cited by this paper
• Is endometrial carcinoma intrinsically more aggressive in elderly patients?

  2003cited by this paper
• Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases.

  2003cited by this paper
• World Health Organization Classification of Tumours

  2002cited by this paper
• Surgical stage I endometrial cancer: predictors of distant failure and death.

  2002cited by this paper
• Uterine papillary serous carcinoma (pure and mixed type) compared with moderately and poorly differentiated endometrioid carcinoma. A clinicopathologic study.

  2002cited by this paper
• Is there a difference in outcome between stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO Grade 3 cancer?

  2002cited by this paper
• Early stage uterine papillary serous carcinoma of the endometrium

  2001cited by this paper
• Clinicopathologic features of BRCA-linked and sporadic ovarian cancer.

  2000cited by this paper
• Minimal uterine serous carcinoma: diagnosis and clinicopathologic correlation.

  2000cited by this paper
• The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.

  2000influential reference
• Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma.

  1999cited by this paper
• Papillary serous and clear cell carcinoma limited to endometrial curettings in FIGO stage 1a and 1b endometrial adenocarcinoma: treatment implications.

  1998cited by this paper
• Uterine papillary serous carcinoma: evaluation of long-term survival in surgically staged patients.

  1998cited by this paper
• Stage IA uterine serous carcinoma: a study of 13 cases.

  1997cited by this paper
• Uterine papillary serous carcinoma (UPSC): a clinicopathologic study of 30 cases.

  1995cited by this paper
• Early pathologic stage clear cell carcinoma and uterine papillary serous carcinoma of the endometrium: comparison of clinicopathologic features and survival.

  1995cited by this paper
• Low‐Stage Clear‐Cell Carcinoma of the Endometrium

  1995cited by this paper
• Uterine papillary serous carcinoma: patterns of metastatic spread.

  1994cited by this paper
• FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina.

  1994cited by this paper
• Uterine papillary serous carcinoma: a study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma.

  1992cited by this paper
• The prognostic significance of surgical staging for carcinoma of the endometrium

  1992cited by this paper
• Surgical pathological staging of endometrial carcinoma and results of treatment.

  1992cited by this paper
• Endometrial adenocarcinoma in Norway. A study of a total population

  1991cited by this paper
• Uterine papillary serous carcinoma

  1987cited by this paper
• Two pathogenetic types of endometrial carcinoma.

  1983cited by this paper
• Uterine papillary serous carcinoma: A highly malignant form of endometrial adenocarcinoma

  1982cited by this paper

• High-grade uterine cancer with ambiguous features - a clinicopathological study.

  2026cites this paper
• Molecular Subtype and Mutational Profile of Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia.

  2025cites this paper
• Prognostic value of "aggressive" histology in surgically staged clinically uterine-confined endometrial carcinoma.

  2025cites this paper
• Unsolved Issues in the Integrated Histo-Molecular Classification of Endometrial Carcinoma and Therapeutic Implications

  2024cites this paper
• Human epidermal growth factor receptor-2 (HER2) expression in FIGO3 high-grade endometrial endometrioid carcinoma: Clinicopathologic characteristics and future directions.

  2024cites this paper
• Incorporating Molecular Classification When Stratifying the Survival Risk of Patients with High-Grade Endometrial Carcinomas

  2023cites this paper
• Histopathological and Immunohistochemical Prognostic Factors in High-Grade Non-Endometrioid Carcinomas of the Endometrium (HG-NECs): Is It Possible to Identify Subgroups at Increased Risk?

  2023cites this paper
• Type II endometrial cancer: Incidence, overall and disease-free survival in Martinique

  2023cites this paper
• Incidence of omental metastasis in uterine serous carcinoma: a systematic review and meta-analysis.

  2022cites this paper
• Low grade endometrial endometrioid adenocarcinoma: A review and update with emphasis on morphologic variants, mimics, immunohistochemical and molecular features.

  2022cites this paper
• Differentiation of carcinosarcoma from endometrial carcinoma on magnetic resonance imaging using deep learning

  2022cites this paper
• Minimally invasive surgery versus open surgery in high-risk histologic endometrial cancer patients: A meta-analysis.

  2022cites this paper
• Various endometrial patterns and abnormalities in women with postmenopausal bleeding

  2022cites this paper
• Clinical Implications of Genomic Loss of Heterozygosity in Endometrial Carcinoma

  2021cites this paper
• Endometrial and Cervical Cancers

  2021cites this paper
• HISTOPATHOLOGICAL AND IMMUNOHISTOCHEMICAL PROGNOSTIC FACTORS IN HIGH-GRADE NON-ENDOMETRIOID CARCINOMAS OF THE ENDOMETRIUM (HG-NECs). IS IT POSSIBLE TO IDENTIFY SUB-GROUPS AT INCREASED RISK?

  2021cites this paper
• High‐risk endometrial cancer proteomic profiling reveals that FBXW7 mutation alters L1CAM and TGM2 protein levels

  2021cites this paper
• Loss of ARID1A Expression as a Favorable Prognostic Factor in Early-Stage Grade 3 Endometrioid Endometrial Carcinoma Patients

  2021cites this paper
• Clinicopathologic characteristics and prognosis comparison of the uterine high grade endometrial carcinomas.

  2021cites this paper
• Unique prognostic features of grade 3 endometrioid endometrial carcinoma: Findings from 101 consecutive cases at a Japanese tertiary cancer center.

  2021cites this paper
• Role of Immunohistochemistry to Distinguish Grade 3 Endometrioid Carcinoma and Uterine Serous Carcinoma

  2020cites this paper
• Napsin-A Expression, a Reliable Immunohistochemical Marker for Diagnosis of Ovarian and Endometrial Clear Cell Carcinomas

  2020cites this paper
• Endometrial Glandular Neoplasia

  2020cites this paper
• Proteomic Analysis of Pre-Invasive Serous Lesions of the Endometrium and Fallopian Tube Reveals Their Metastatic Potential

  2020cites this paper
• High-grade endometrial cancer survival (endometrioid to non-endometrioid histology comparison)

  2020cites this paper
• Comparison of clinicopathologic and survival characteristics of high grade endometrial cancers; single center experience.

  2019cites this paper
• Does the Increased Rate of Serous Component (≤25% vs. >25%) Increase Recurrence in Endometrial Cancer With Serous Plus Endometrioid Histology?

  2019cites this paper
• Endometrial Cancer Genetic Classification and Its Clinical Application

  2019cites this paper
• Endometrial Carcinoma

  2019cites this paper
• Adenocarcinoma, Carcinosarcoma, and Other Epithelial Tumors of the Endometrium

  2018cites this paper
• The evolution of endometrial carcinoma classification through application of immunohistochemistry and molecular diagnostics: past, present and future

  2018cites this paper
• Minichromosome maintenance complex component 6 (MCM6) expression correlates with histological grade and survival in endometrioid endometrial adenocarcinoma

  2018cites this paper
• High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features, Diagnostic Challenges and Recommendations

  2018cites this paper
• Uterine sarcomas

  2018cites this paper
• Uterine Cancer

  2018influential citation
• 18 Prevention and Therapeutic Strategies in Endometrial Cancer

  2018cites this paper
• Evolving Roles of Histologic Evaluation and Molecular/Genomic Profiling in the Management of Endometrial Cancer.

  2018cites this paper
• Caracterización molecular de los carcinosarcomas de endometrio.

  2018cites this paper
• Gynecologic Cancers: Molecular Updates 2018.

  2018cites this paper
• Are the uterine serous carcinomas underdiagnosed? Histomorphologic and immunohistochemical correlates and clinical follow up in high-grade endometrial carcinomas initially diagnosed as high-grade endometrioid carcinoma

  2018cites this paper
• Infrequent Immunohistochemical Expression of Napsin A in Endometrial Carcinomas

  2017cites this paper
• Recent Developments in Surgical Pathology of the Uterine Corpus.

  2017cites this paper
• Chapter 2 Pathology of Gynecologic Cancer

  2017cites this paper
• Negrini ENDOMETRIAL CARCINOMAS WITH MISMATCH REPAIR DEFICIENCY : IMMUNOPHENOTYPICAL AND MOLECULAR CHARACTERIZATION

  2017cites this paper
• Endometrial cancer evolution: new molecular-biologic types and hormonal-metabolic shifts.

  2017cites this paper
• Uterine Clear Cell Carcinoma

  2017cites this paper
• Endometrial Cancer Genomics

  2017cites this paper
• Utility of radiation therapy for early-stage uterine papillary serous carcinoma.

  2017cites this paper
• Fascin Is Associated With Aggressive Behavior and Poor Outcome in Uterine Carcinosarcoma

  2017cites this paper
• Accuracy of Endometrial Sampling in Endometrial Carcinoma: A Systematic Review and Meta-analysis.

  2017cites this paper
• Endometrial cytopathology. An image analysis approach using the Ki‐67 biomarker

  2017cites this paper
• Uterine Papillary Serous Carcinoma—Still an Enigma?

  2017cites this paper
• Clinicopathological analysis of mixed endometrial carcinomas: clinical relevance of different neoplastic components.

  2017cites this paper
• Endometrial adenocarcinoma: Current concepts

  2016cites this paper
• Endometrial Carcinoma: Role of Current and Emerging Biomarkers in Resolving Persistent Clinical Dilemmas.

  2016cites this paper
• Expression of PD-1, PD-L1 and PD-L2 is associated with differentiation status and histological type of endometrial cancer

  2016cites this paper
• Similar protein expression profiles of ovarian and endometrial high-grade serous carcinomas

  2016influential citation
• An update of the classical Bokhman's dualistic model of endometrial cancer

  2016cites this paper
• Interobserver Variability in the Diagnosis of Uterine High-Grade Endometrioid Carcinoma.

  2016cites this paper
• Practical issues in the diagnosis of serous carcinoma of the endometrium

  2016cites this paper
• Clusterin immunoexpression is associated with early stage endometrial carcinomas.

  2016cites this paper
• SLUG expression is an indicator of tumour recurrence in high‐grade endometrial carcinomas

  2016cites this paper
• The Genomic Heterogeneity of FIGO Grade 3 Endometrioid Carcinoma Impacts Diagnostic Accuracy and Reproducibility

  2016cites this paper
• Survival Differences Among Uterine Papillary Serous, Clear Cell and Grade 3 Endometrioid Adenocarcinoma Endometrial Cancers: A National Cancer Database Analysis

  2016cites this paper
• Analysis of Clinical and Pathological Characteristics, Treatment Methods, Survival, and Prognosis of Uterine Papillary Serous Carcinoma

  2016cites this paper
• A Study of Expression of Thyroid Transcription Factor (ttf-1) in Endometrial Adenocarcinoma of Uterine Corpus.

  2016cites this paper
• Leptin expression in stromal cells of endometrial carcinomas is associated with advanced stage and disease recurrence

  2016cites this paper
• Loss of c-met expression in malignant endometrial tumors: an immunohistochemistry study

  2016cites this paper
• The prognostic significance of tumour-stroma ratio in endometrial carcinoma

  2015cites this paper
• Molecular Analysis of Mixed Endometrioid and Serous Adenocarcinoma of the Endometrium

  2015cites this paper
• PPP2R1A mutations in gynaecologic cancers: functional characterization and use in the genomic classification of tumours

  2015cites this paper
• Prognostic Factors in Uterine Cancer

  2015cites this paper
• Immunohistochemical study of endometrial high‐grade endometrioid carcinoma with or without a concurrent low‐grade component: implications for pathogenetic and survival differences

  2015cites this paper
• Uterine sarcomas

  2015cites this paper
• Canadian high risk endometrial cancer (CHREC) consortium: analyzing the clinical behavior of high risk endometrial cancers.

  2015cites this paper
• Preoperative neutrophil:lymphocyte and platelet:lymphocyte ratios predict endometrial cancer survival

  2015cites this paper
• Prognostic significance of overexpression of p53 in uterine endometrioid adenocarcinomas with an analysis of nuclear grade

  2014cites this paper
• Molecular targets and targeted therapy

  2014cites this paper
• Survival analysis of pelvic lymphadenectomy alone versus combined pelvic and para-aortic lymphadenectomy in patients exhibiting endometrioid type endometrial cancer

  2014cites this paper
• Endometrial Cancer—Pathology and Genetics

  2014cites this paper
• Prognostic factors and treatment outcomes for patients with surgically staged uterine clear cell carcinoma focusing on the early stage: A Taiwanese Gynecologic Oncology Group study.

  2014cites this paper
• Cytodiagnosis of endometrial carcinoma and hyperplasia on imprint smears with additional immunocytochemistry using Ki‐67 and p53 biomarkers

  2014cites this paper
• The Occurrence of Fetal Microchimeric Cells in Endometrial Tissues Is a Very Common Phenomenon in Benign Uterine Disorders, and the Lower Prevalence of Fetal Microchimerism Is Associated with Better Uterine Cancer Prognoses

  2014cites this paper
• Utility of Ki‐67, p53, Bcl‐2, and Cox‐2 biomarkers for low‐grade endometrial cancer and disordered proliferative/benign hyperplastic endometrium by imprint cytology

  2014cites this paper
• Classification of endometrial carcinoma: more than two types.

  2014cites this paper
• Immunohistochemical characterization of prototypical endometrial clear cell carcinoma—diagnostic utility of HNF‐1β and oestrogen receptor

  2014cites this paper
• Oncomorphic Tp53 mutations in advanced serous ovarian carcinomas

  2014cites this paper
• An investigation into tetraspanin CD151 as novel prognostic markers in poor outcome endometrial cancer

  2014cites this paper
• Immunohistochemical characterization of endometrial carcinomas: Endometrioid, serous and clear cell adenocarcinomas in association with genetic analysis

  2014influential citation
• Frequent Expression of Napsin A in Clear Cell Carcinoma of the Endometrium: Potential Diagnostic Utility

  2014cites this paper
• Une métastase isolée au niveau du grêle d’un adénocarcinome de l’endomètre

  2014cites this paper
• Management of uterine sarcoma

  2014cites this paper
• Poor prognosis of uterine serous carcinoma compared with grade 3 endometrioid carcinoma in early stage patients

  2013influential citation
• Redefining Stage I Endometrial Cancer: Incorporating Histology, a Binary Grading System, Myometrial Invasion, and Lymph Node Assessment

  2013cites this paper
• Genetics of Endometrial Carcinoma

  2013cites this paper
• Prognostic significance and diagnostic value of PTEN and p53 expression in endometrial carcinoma. A retrospective clinicopathological and immunohistochemical study.

  2013cites this paper
• ER+/PR+/TFF3+/IMP3− immunoprofile distinguishes endometrioid from serous and clear cell carcinomas of the endometrium: a study of 401 cases

  2013cites this paper
• High‐grade endometrial carcinomas – strategies for typing

  2013cites this paper
• Early stage uterine serous carcinoma: management updates and genomic advances.

  2013cites this paper
• Comparative outcomes assessment of uterine grade 3 endometrioid, serous, and clear cell carcinomas.

  2013cites this paper